Clinical Manifestations of HBsAg and Anti-HCV Negative Chronic Liver Disease in Nagasaki Prefecture, Japan

Internal Medicine

Volumn 35, Issue 8, 1996, Pages 600-604

  Omagari, Katsuhisa ^a   Komatsu, Kohei ^a   Kato, Yuji ^a   Nakata, Keisuke ^a   Kusumoto, Yukio ^b   Mori, Iwao ^b   Furukawa, Ryuji ^c   Tanioka, Hajime ^d   Tajima, Heiichiro ^e   Koga, Michiaki ^f   Yano, Michitami ^f  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki City Hospital   (Japan)

^c Japanese Red Cross Nagasaki Atomic Bomb Hospital   (Japan)

^d Sasebo Shiritsu Sogo Hospital   (Japan)

^e Nagasaki Rousai Hospital   (Japan)

^f Nagasaki Chuo National Hospital   (Japan)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Long term prognosis; Non B; Non C chronic liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; TIME; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CHILD; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030202960     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.600     Document Type: Article

References (21)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359, 1989.
2. Hamasaki K, Nakata K, Tsutsumi T, et al. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 40: 146, 1993.
3. Matsuo A, Kusumoto Y, Ohtsuka E, et al. Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan. Lancet 335: 955, 1990.
4. Uchida T, Aye TT, Becker SO, et al. Detection of precore/core-mutant hepatitis B virus (HBV) genome in patients with acute or fulminant hepatitis without serological markers for recent HBV infection. J Hepatol 18: 369, 1993.
5. Schlauder GG, Mushahwar IK. Detection of hepatitis C and E virus by the polymerase chain reaction. J Virol Methods 47: 243, 1994.
6. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564, 1995.
7. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 89: 1836, 1994.
8. Marcellin P, Martinot-Peignoux M, Gabriel F, et al. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. J Hepatol 19: 167, 1993.
9. Uchida T, Shimojima M, Gotoh K, Shikata T, Tanaka E, Kiyosawa K. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 38: 281, 1994.
10. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 345: 413, 1995.
11. Deka N, Sharma MD, Mukerjee R. Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis. J Virol 68: 7810, 1994.
12. Phillips MJ, Blendis LM, Poucell S, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 324: 455, 1991.
13. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 34: S13, 1993.
14. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439, 1983.
15. Inoue O, Koga M, Yatsuhashi H, Yano M. The natural course of anti-HCV positive non-A, non-B chronic hepatitis in comparison with that of type B chronic hepatitis: a clinical and histological investigation. in: Viral Hepatitis C, D and E, Shikata T, Purcell RH, Uchida T, Eds. Elsevier Science Publishers B. V., Amsterdam-New York-Oxford, 1991, p.103.
16. Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74: 2234, 1994.
17. Takada S, Koike K. Trans-activating function of a 3'truncated X gene cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87: 5628, 1990.
18. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21: 650, 1995.
19. Oka H, Kuroki N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12: 680, 1990.
20. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328: 1797, 1993.
21. Hu K-Q, Yu C-H, Lee S, Villamil FG, Vierling JM. Simultaneous detection of both hepatitis B virus DNA and hepatitis C virus RNA using a combined one-step polymerase chain reaction technique. Hepatology 21: 901, 1995.